KCNJ11 and diabetes mellitus: KCNJ11 gene screening is currently indicated by guidelines in all patients who present with diabetes diagnosed before 6–12 months of age since some studies reported that families of patients with a transient or permanent form of NDM can also include individuals with childhood or later-onset diabetes.